Stool
PreclinicalBiologic
Stool is one of 15 biologic programs targeting Colitis. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
14
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
16 competitors in Colitis
#DrugCompanyPhaseTrials
1Simponi
Johnson & JohnsonApproved
Deltasone
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Imuran
LLegacy Health System
Approved
Cortef
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Remicade
Johnson & JohnsonPhase 3
Medrol
PfizerPhase 3
Entyvio
TakedaPhase 2
Lialda
TakedaPhase 2
Rayos
RRoxane Laboratories
Phase 2
Actigall
AbbViePhase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Stool. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- OOSF Healthcare System